Latest Developments
03 February 2011
A5 Laboratories has received approval letter for it’s containment level 2 facility.
MONTREAL, QUEBEC–(Marketwire – 02/03/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the office of Biohazard and Containment Safety
01 February 2011
A5 Laboratories, Inc. Announces Successful Production of VI-1718 Interferon Product
MONTREAL, QUEBEC–(Marketwire – 02/01/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the successful production of its VI-1718 interferon product by its European manufacturing partner.
Quality Assurance
Quality Assurance & Support Services:
The A5 Laboratories Quality Assurance department independently audits and tracks every project to ensure accurate and reliable results. Every report includes a Quality Assurance Letter verifying and qualifying data and compliance, which completes the audit trail.